bisindolylmaleimide i and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

bisindolylmaleimide i has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cenac, N; Hollenberg, MD; Houle, S; Hyun, E; Liblau, RS; Ramachandran, R; Rousset, P; Saxena, A; Vergnolle, N1

Other Studies

1 other study(ies) available for bisindolylmaleimide i and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ArticleYear
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Mar-01, Volume: 184, Issue:5

    Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Ganglia, Spinal; Humans; Hypoglycemic Agents; Immunity, Innate; Indoles; Inflammation; Insulin; Leukocyte Rolling; Male; Maleimides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Neurons; Oligopeptides; Receptor, PAR-2; Signal Transduction

2010